Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong New Era Pharmaceutical Co., Ltd., a core subsidiary of the Lunan Pharmaceutical Group, is a prominent Chinese pharmaceutical company based in Linyi, Shandong. Established in 2002, the company integrates research, development, and large-scale production of active pharmaceutical ingredients (APIs) and finished formulations. Its extensive portfolio covers therapeutic areas including oncology, cardiovascular disease, diabetes, and obesity, featuring high-demand products such as Orlistat and Acarbose. The firm maintains state-of-the-art manufacturing facilities that adhere to global quality standards, including US FDA and EU GMP certifications, supporting its role as a significant player in the international pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NEW ERA CHEMICAL Shandong.